Here’s what you should know:
1. Plenvu additionally focuses on preparing the ascending colon.
2. If approved, Plenvu will tout the lowest total volume of solution for a bowel cleanser.
3. Salix expects an FDA decision in the first quarter of fiscal year 2018.
4. Salix is a subsidiary of Valeant Pharmaceuticals.
More articles on gastroenterology:
Synthetic Biologics receives Patent office allowance for active agent in IBS-C treatment — 3 key notes
GI center to know: Gastroenterology of the Rockies
Exact Sciences partners with pro-golfer & more — 6 GI company key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.